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Background: When selecting blood donors in transfusion centres, one important problem is to identify, during
screening, individuals with infectious diseases that can be transmitted by blood, such as malaria, especially when
the parasite densities are very low. This problem is particularly severe in endemic areas, such as the Brazilian
Amazon. In the present study, molecular diagnostic (real-time PCR) of Plasmodium vivax was used to identify blood
donors infected with malaria parasites.
Methods: Samples from 595 blood donors were collected in seven haemotherapy centres in northern Brazil
located in areas at risk for malaria transmission, and the analyses were performed by real-time PCR with TaqMan
probes on 7500 Real-Time PCR Systems, to genotype the mitochondrial DNA region specific to P. vivax. The
experiment was designed for hybridization of the cytochrome c oxidase genes of the mitochondrial genome
(GenBank GI63022502). The serological data were obtained using enzyme-linked immunosorbent assay - ELISA
(Anti-HIV, Anti-HTLV I-II; Anti-HVC, HBsAg, Anti-HBc, Chagas disease) and VDRL (Syphilis) from the Blood Bank System
of the Haematology and Haemotherapy Centre of Pará.
Results: The assay identified eight individuals in the sample (1.34%) infected with P. vivax at the time of blood
donation. This percentage was higher than the altered serological results (reactive or inconclusive) of the
prevalence of anti-HIV (0.67%), anti-hepatitis C virus (0.34%), anti-hepatitis B surface antigen (0.67%), anti-human
T-lymphotropic virus I/II (1.18%), anti-Chagas disease (0.17%) and syphilis (VDRL) (0.50%), but not higher than
anti-hepatitis B core antigen antibodies (4.37%). This result indicates the need to use more sensitive methods of
diagnosing malaria in blood banks.
Conclusion: The real-time PCR with TaqMan probes enabled the identification of P. vivax in a high proportion of
clinically healthy donors, highlighting the potential risk for transfusion-transmitted malaria. Additionally, this
molecular diagnostic tool can be adopted as a new laboratory screening method in haemotherapy centres,
especially in malaria-endemic areas.
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Malaria is recognized as a serious public health problem,
occurring in tropical and regions such as Africa, Asia
and Central and South America. In 2010, there were an
estimated 216 million new cases of malaria, with
655,000 deaths [1]. Further, in malaria transmission
areas asymptomatic carriers of Plasmodium have been
described, including studies carried out in South Amer-
ica [2,3].* Correspondence: akely@ufpa.br
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distribution, and reproduction in any mediumIn Brazil, malaria is endemic in the Amazon region,
with 98% of the cases in the year 2009. Malaria trans-
mission is unstable and usually focal, and the period of
highest transmission occurs after the rainy season. The
vast geographical extent and the climatic conditions of
the Amazon region favour transmission of the species
Plasmodium vivax, Plasmodium falciparum and Plasmo-
dium malariae. Plasmodium vivax is the most prevalent
species, causing approximately 83.7% of reported cases
in 2009 [4].
Malaria is transmitted by the bite of the female Anoph-
eles mosquito but also by congenital transmission and,
rarely, by blood transfusion and the sharing of needlesed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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transmitted malaria dates back to 1882, when Gerhardt
empirically demonstrated the transmission of malaria in
humans by infected blood [7]. However, the first case of
accidental transmission by blood transfusion was
described in 1911 [8].
The risk of transfusion-transmitted malaria (TTM) has
been associated with the difficulty in identifying infected
potential donors, most with low numbers of parasites
circulating in the blood (incomplete immunity), as well
as the ability of this parasite to remain viable in stored
blood bags, even after the storage process [9,10]. Thus,
any blood component may harbour viable parasites.
Whole blood and concentrated erythrocytes represent
the most common sources of TTM; however, there have
also been cases of transmission through platelet concen-
trates, leukocyte concentrates, cryoprecipitate (contami-
nated by residual erythrocytes) and frozen erythrocytes
after thawing and washing. Transmission through freshly
frozen plasma has not been reported [9,10].
Additionally, in cases of TTM, depending on the num-
ber of parasites in the inoculum, the symptoms of mal-
aria may begin days or weeks after transfusion [11],
presenting as a serious and often fatal disease [12]. Thus,
the transfusion practice constitutes a major challenge in
malaria-endemic areas because many potential blood
donors are infected. This situation could jeopardize the
attainment of blood and blood products for transfusion
demand in areas where the refusal of donation is high
[9]. Another difficulty is the lack of parasite-diagnostic
methods that are sensitive, specific and easily reprodu-
cible in endemic areas and are focused on laboratory
screening of blood donors [11-13].
Currently, in countries where malaria is endemic, such
as Brazil, TTM control is based on clinical interviews of
potential donors to identify residents and travellers from
high-risk endemic areas, individuals with infection and a
history of malaria and those with a history of fever that
precedes blood donation. Additionally, in Brazil, labora-
torial diagnosis in blood banks, in endemic areas with
active transmission and in non-endemic areas (whose
candidates for blood donation are from cities located in
endemic areas) is recommended for the detection of
parasites [14,15].
The scientific community has been concerned with the
low sensitivity and specificity of the different methods
used for laboratory investigation of malaria parasites. In
practice, the gold-standard technique, optical micros-
copy in thick blood smears, is used widely for Plasmo-
dium detection in endemic areas but cannot identify
parasites at low densities. This technique detects quan-
tities between 5 and 20 parasites/μL of blood, and the
results depend on the experience of the microscopist
[11,15-18]. In parallel, new techniques have beendeveloped for laboratory screening of malaria, with the
aim of selecting potential blood donors, such as the
rapid diagnostic tests [17,19], enzyme-linked immunoab-
sorbent assay (ELISA) for P. falciparum antigen [20].
However, this technique has low sensitivity at low levels
of antigens, ranging from 100 to 1,000 parasites/μL of
blood, according to the species and method used
[8,11,17]. ELISA technique for antibody was evaluated
[21], but this serological screening has limitation to con-
firm malaria infection.
Methods based on molecular biology have been used
to detect different types of Plasmodium by PCR, such as
the nested PCR [22,23]. This technique is based on the
amplification of a fragment of the small subunit riboso-
mal RNA (ssrRNA) of the parasite by nested PCR and
has been employed for the diagnosis of malaria for re-
search and reference laboratories [17,18,24-27]. The
PCR technique can detect parasites below the threshold
levels of microscopy; when performed under optimal
conditions, PCR can detect parasitaemia as low as 0.01
to 1 parasite/μL of blood [17,18]. The results directly de-
pend on the quality of the genetic material (DNA) of the
parasite obtained during extraction and amplification
and on the quality of the reagents, and the test requires
a long analysis time. Despite the increased sensitivity,
PCR has not been established as a routine diagnostic
method in laboratories or blood banks [16,18,21,26,27].
The detection of malaria infection by real-time PCR is
considered, at the moment, the best molecular biology
technique available and shows that real-time PCR has
high sensitivity and specificity to detect malaria parasites
in the blood [21,24,27]. This technique prevents ambigu-
ous results because it does not require agarose gels,
minimizes manual work, reduces pipetting errors, per-
forms well under high throughput and provides quanti-
tative results of parasite density [27].
The present study employed real-time PCR with Taq-
Man probes to detect P. vivax through the amplification
of mitochondrial DNA (mtDNA), the use of this se-
quence for malaria diagnosis was first described in 2009
[28], and in this study, real-time PCR technique was




A total of 595 blood samples from the blood donor
archives of seven haemotherapy centres in the state of
Pará, Brazil, were investigated during April to July 2010.
The samples came from municipalities that had a vari-
able annual parasite incidence (API) (number of positive
tests for malaria per thousand inhabitants in a given
geographical area) in 2009. Each API was classified as
low in relation to the endemic level of malaria based on
Table 1 Prevalence of Plasmodium vivax among blood
donors from haematology and haemotherapy services
(HHS) detected by molecular diagnosis RT-PCR based on
amplification of mitochondrial DNA





HHS of Belém 72 0.5 (Low) 0 (0.0)
HHS of Marabá 111 5.7 (Low) 0 (0.0)
HHS of Santarém 121 3.5 (Low) 3 (2.5)
HHS of Abaetetuba 148 0.2 (Low) 5 (3.4)
HHS of Redenção 28 0.2 (Low) 0 (0.0)
HHS of Tucuruí 33 15.5 (Medium) 0 (0.0)
HHS of Altamira 82 17.5 (Medium) 0 (0.0)
Total 595 8 (1.34)
* API: Annual Parasite Incidence (number of positive per 1,000 inhabitants;
IPA<10: low; 10–49: medium, and ≥50 high) and risk of malaria in each area
estimated in 2009 by Brazilian system in health surveillance.
Batista-dos-Santos et al. Malaria Journal 2012, 11:345 Page 3 of 6
http://www.malariajournal.com/content/11/1/345the Brazilian Ministry of Health data registered in 2009
[29]. Donors residing in municipalities with low API
included 72 donors from the Blood Bank Coordinator
(Haemotherapy Centre of Belém, API 0.5, classified as
low endemic level), 111 donors from the Regional Blood
Bank of Marabá (Haemotherapy Centre of Marabá, API
5.7, low endemic level), 121 donors from the Regional
Blood Bank of Santarém (Haemotherapy Centre of San-
tarém, API 3.5, low endemic level, 148 donors from the
Blood Bank of Abaetetuba (Hemonucleo Abaetetuba,
API 0.2, low endemic level, and 28 from the Blood Bank
of Redenção (Hemonucleo Redenção, API, 0.2, low en-
demic level). Donors residing in municipalities with
medium API included 33 donors from the Blood Bank
of Tucuruí (Hemonucleo Tucuruí, API 15.5 and 82
donors from Altamira, Hemonucleo Altamira, API 17.5).
All donors had previously been subjected to clinical
screening based on the National Health Surveillance
Agency [30]. Individuals of both genders between the
ages of 18 and 65 years were included. The serological
data were obtained from the Blood Bank System of the
Hematology and Haemotherapy Centre of Pará. The
samples were testes using ELISA - enzyme-linked im-
munosorbent assay (Anti-HIV; Anti-HTLV I-II; Anti-
HVC, HBsAg, Anti-HBc, Chagas disease) and VDRL
(Syphilis). The present study was conducted with the
consent and approval of the Research Ethics Committee
of the Haematology and Haemotherapy Centre of Pará.
Blood samples from the donors
Blood samples were collected in EDTA anti-coagulant.
From each individual 3 mL of venous blood was
obtained from the archives of blood donor samples of
the Haematology and Haemotherapy Centre of Pará,
Brazil, corresponding to the period from April to July
2010. All samples were stored at −20°C until DNA
extraction.
DNA extraction and quantification
DNA was extracted by the phenol/chloroform method
[31], with modifications. After extraction, the DNA was
quantified on a NanoDrop™1000 (Thermo Scientific, WI,
USA).
Real-time PCR (PCRRT)
In general, the strategy for determining the presence or
absence of P. vivax genomic DNA was based on primer
extension and subsequent hybridization with specific
probes. DNA segments were amplified by the method of
presence and absence by real-time PCR with TaqManW
probes, 7500 Real-Time PCR Systems and 7500 System
SDS software (Life Technologies, CA, USA). For this
purpose, the probe was labelled (6-FAM) differently
from the DNA region of interest. The primers andprobes were designed with the software Custom TaqMan
Genomic Assays File Builder, Version 3.0, and a kit was
developed.
Plasmodium vivax mtDNA was genotyped according
to the manufacturer's instructions (Life Technologies).
The reactions were prepared in duplicate at a final vol-
ume of 15 μL. The reactions were normalized by the use
of an endogenous internal positive control (Life Tech-
nologies). As experimental calibrators of the reaction,
samples from individuals with proven infection and not
infected with P. vivax were used. The experiment was
designed for hybridization of the cytochrome c oxidase
genes of the mitochondrial genome. This sequence was
based on the P. vivax genome (Cox I - Access Number
GI63022502) available at GenBank. The primers used
were previously published [28], with modifications for
real-time PCR.Statistical analysis
A ratio test was used to measure the percentage of
donors who had P. vivax genetic material in the hae-
motherapy centres investigated in the present study. A
Student-T and chi-square were used as statistical test to
compare the samples’ attributes.Results
The present study evaluated the applicability of real-
time PCR to the detection of P. vivax DNA in blood
samples derived from blood donor archives of the
Haematology and Haemotherapy Centre of Pará, Brazil.
A total of 595 donor samples from seven haemotherapy
centres were evaluated, all in municipalities considered
endemic for malaria in the state of Pará according to
the API classification. In donor samples investigated by
Table 2 Number of samples detected by RT-PCR for
Plasmodium vivax according to age groups and gender
Age (year) Negative samples Positive samples
Female Male Female Male
18 - 26 62 155 3 5
27 - 35 40 141 0 0
36 - 44 33 73 0 0
45 - 53 17 39 0 0
54 - 65 11 16 0 0
The negative samples´ average age (32.71) and positive samples´ average age
(23.12) were statistical different (t=22.9909; p>0.0001). There is no statistical
difference between gender in the sample ( χ2=0.16; p=0.317).
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the presence of P. vivax DNA (Table 1). The collection
of donor blood samples considered positive for P. vivax
occurred during the months of May (two/eight cases),
April (five/eight cases) and June (two/eight cases). The
positive samples originated from two haemotherapy
centres: three samples from donors at the Regional
Blood Bank of Santarém and five samples from the
Blood Bank of Abaetetuba. All samples positive for
P. vivax belonged to municipalities with low API.
The samples positive for P. vivax included three sam-
ples from women (three/166 women) and five from men
(five/429 men). All positive samples were within the age
range of 18 to 26 years, and their average age was 23.12
(Table 2). Two samples positive for P. vivax had their
serology altered by other blood-transmitted agents: one
individual was HIV-reactive and one HTLV I-II incon-
clusive (Table 3). The data from the analysed samples
according to the standard serological results for donor
screening and the real-time PCR results for P. vivax
showed significant differences relating to age (p>0.0001),
but no difference relating to gender (p=0.317) of donors
(Table 2).Table 3 Serological data observed in standard screening
donors and number of Plasmodium vivax positive
samples detected by RT-PCR
Standard serology screening donors RT-PCR P. vivax





Anti-HIV 1/595 3/595 1
Anti-HTLV I-II 1/595 6/595 1
Anti-HVC 2/595 0/595 0
HBsAg 4/595 0/595 0
Anti-HBc 18/595 8/595 0
Chagas disease 0/595 1/595 0
Syphilis (VDRL) 3/595 - 0
Non-reagent 566/595 577/595 6Discussion
The present work proposes an improved technique
based on amplification of mitochondrial DNA to detect
P. vivax, previously described [28], using real-time PCR
with TaqMan probes in a sample of 595 blood donors.
Currently, the technique most often used in endemic
areas is the gold standard of objective microscopy in
thick blood smears. This technique is considered the
most effective and inexpensive for the diagnosis of mal-
aria. However, its low sensitivity and specificity in situa-
tions of low-parasite density hinder the detection of
asymptomatic donors who have small amounts of para-
sites at the time of donation. This fact presents a trans-
fusion risk for the recipient, and parasite detection
depends on the experience of the microscopist, takes
time for the analysis and hinders a rapid evaluation
[8,27], such as in blood donation.
Techniques recommended in Brazil, such as the use of
plasmodial antigens to select blood donation, e g, with
the ELISA-Malaria Antigen Test, have low sensitivity
(100 to 1,000 parasites/μL), and rapid diagnostic test.
Thus, these techniques show even lower sensitivity than
optical microscopy in thick blood smears [11,17,19].
Three previous publications based on molecular biol-
ogy techniques [22,23,28] describe methods to identify
the malaria parasite. The first two methods employ pre-
ferential amplification of nuclear DNA by nested PCR,
followed by electrophoresis in agarose (or acrylamide)
and subsequent staining of the DNA with ethidium
bromide. The diagnostic target is the amplification of the
parasite's nuclear DNA. The main disadvantage of these
methods is the limited number of copies of the parasite
nuclear DNA (only one copy/parasite), which reduces
the chances of identifying the parasite in low parasit-
aemia, as expected from blood donor samples from
asymptomatic carriers. Moreover, conventional PCR fol-
lowed by ethidium bromide staining and visual reading is
much less sensitive than techniques that employ fluores-
cence readings, such as real-time PCR. All these charac-
teristics may decrease the probability of detecting the
actual genetic material of the parasite (producing false-
negative results) and reduce the reproducibility of the
technique due to the interference of other, external fac-
tors, such as the method of DNA extraction, the
method of DNA amplification and the dye used.
The third method [28] uses the classical PCR tech-
nique to identify the presence of mtDNA cytochrome c
oxidase specific to P. vivax and P. falciparum. The main
advantage of this method compared to the others is due
to the diagnostic target (mtDNA), which is more numer-
ous than nuclear DNA. The number of copies/cell of the
mtDNA genome can range from 20 to 100 [32,33].
In the present study, the method previously deve-
loped [28] has been improved by using the same
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method with real-time PCR, which uses, in addition to
the hybridization of two primers, a specific,
fluorescence-labelled TaqMan probe. The ability to im-
prove the identification of parasite DNA increases the
probability of diagnosing asymptomatic donors with
very low detection limits, making this method valuable,
novel and extremely sensitive, surpassing the other
techniques adopted to date [34].
Although malaria affects all ages, the present study
showed a higher concentration of positive donors be-
tween the ages of 18 and 26 (8 individuals), where all
positive belong this range. This result confirms the
greater risk of and exposure to malaria infection in
adults. This pattern may be the result of professional ac-
tivities that foster individual exposure to the mosquito
vector.
By comparing, within the same analysed samples, the
real-time PCR results for P. vivax with altered serology
(reactive and inconclusive cases) for different blood-
borne diseases, the positivity for malaria was more
common than the positivity for other pathogens. Be-
cause the presence of any serological alteration, by it-
self, is reason for discarding the donor’s blood, the
presence of P. vivax mtDNA also increases the risk of
infection and necessitates the disposal of the donated
blood. Therefore, testing for Plasmodium or its vestiges
should be recommended.
The detection of P. vivax by classical molecular diag-
nosis (standard PCR) in haemotherapy centres has been
described [26]. In that study the authors presented a
positivity rate ranging from 1 to 3% in blood donors
from four Amazonian areas. All positive individuals had
infections of P. vivax and P. falciparum, with an average
positivity rate of 2.3% among blood donors from four
blood banks of the Amazon. The present study found a
P. vivax-positive rate of 1.34% in two haemotherapy cen-
tres, the Blood Bank of Abaetetuba and the Regional
Blood Bank of Santarém, both located in the state of
Pará, in municipalities described to have low risk for
malaria transmission with API 0.2 and 3.5, respectively.
Interestingly, seven positive cases of P. vivax were
detected in donors living in the cities where the blood
banks are located (Santarém and Abaetetuba, Pará), and
only one case was from a donor residing in a rural area
near the Blood Bank of Abaetetuba. However, consider-
ing the continuous flow between urban and rural areas
(mainly due to economic activities) and the proximity of
the blood centres to the forest, the actual infection sites
may not have been in urban areas.
Therefore, the presence of the P. vivax mtDNA is a
feasible, accurate, sensitive marker for detecting low-
level malaria parasitaemia. All these data highlight the
need to adopt new identification techniques with bettersensitivity and specificity for malaria research, such as
real-time PCR.
Conclusion
The method to detect mtDNA of P. vivax by real-time
PCR was able to identify carriers of this parasite among
a relatively high proportion of clinically healthy blood
donors. The results from this study indicate that real-
time PCR-based laboratory screening for the presence of
P. vivax is a method that is necessary, appropriate and
inexpensive, with superior sensitivity and specificity
compared to previously described methods, and can be
adopted as part of the laboratory screening in hae-
motherapy centres, especially in malaria-endemic areas.
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